287 related articles for article (PubMed ID: 11298806)
1. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats.
Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Upton N; Porter RA; Johns A; Blundell JE
Eur J Neurosci; 2001 Apr; 13(7):1444-52. PubMed ID: 11298806
[TBL] [Abstract][Full Text] [Related]
2. Dose-response effects of orexin-A on food intake and the behavioural satiety sequence in rats.
Rodgers RJ; Halford JC; Nunes de Souza RL; Canto de Souza AL; Piper DC; Arch JR; Blundell JE
Regul Pept; 2000 Dec; 96(1-2):71-84. PubMed ID: 11102655
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of the selective orexin-1 receptor antagonist SB-334867 and lithium chloride on the behavioural satiety sequence in rats.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
Physiol Behav; 2004 Mar; 81(1):129-40. PubMed ID: 15059692
[TBL] [Abstract][Full Text] [Related]
4. Satiety enhancement by selective orexin-1 receptor antagonist SB-334867: influence of test context and profile comparison with CCK-8S.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Rodgers RJ
Behav Brain Res; 2005 May; 160(1):11-24. PubMed ID: 15836896
[TBL] [Abstract][Full Text] [Related]
5. A selective orexin-1 receptor antagonist reduces food consumption in male and female rats.
Haynes AC; Jackson B; Chapman H; Tadayyon M; Johns A; Porter RA; Arch JR
Regul Pept; 2000 Dec; 96(1-2):45-51. PubMed ID: 11102651
[TBL] [Abstract][Full Text] [Related]
6. Effects of centrally administered orexin-B and orexin-A: a role for orexin-1 receptors in orexin-B-induced hyperactivity.
Jones DN; Gartlon J; Parker F; Taylor SG; Routledge C; Hemmati P; Munton RP; Ashmeade TE; Hatcher JP; Johns A; Porter RA; Hagan JJ; Hunter AJ; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):210-8. PubMed ID: 11205421
[TBL] [Abstract][Full Text] [Related]
7. Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement.
Duxon MS; Stretton J; Starr K; Jones DN; Holland V; Riley G; Jerman J; Brough S; Smart D; Johns A; Chan W; Porter RA; Upton N
Psychopharmacology (Berl); 2001 Jan; 153(2):203-9. PubMed ID: 11205420
[TBL] [Abstract][Full Text] [Related]
8. Orexins and appetite regulation.
Rodgers RJ; Ishii Y; Halford JC; Blundell JE
Neuropeptides; 2002 Oct; 36(5):303-25. PubMed ID: 12450737
[TBL] [Abstract][Full Text] [Related]
9. Anorexia and weight loss in male rats 24 h following single dose treatment with orexin-1 receptor antagonist SB-334867.
Ishii Y; Blundell JE; Halford JC; Upton N; Porter R; Johns A; Jeffrey P; Summerfield S; Rodgers RJ
Behav Brain Res; 2005 Feb; 157(2):331-41. PubMed ID: 15639184
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the role of hindbrain orexin-1 receptors in the control of meal size.
Parise EM; Lilly N; Kay K; Dossat AM; Seth R; Overton JM; Williams DL
Am J Physiol Regul Integr Comp Physiol; 2011 Dec; 301(6):R1692-9. PubMed ID: 21957165
[TBL] [Abstract][Full Text] [Related]
11. The orexin-1 receptor antagonist SB-334867 blocks the effects of antipsychotics on the activity of A9 and A10 dopamine neurons: implications for antipsychotic therapy.
Rasmussen K; Hsu MA; Yang Y
Neuropsychopharmacology; 2007 Apr; 32(4):786-92. PubMed ID: 17063151
[TBL] [Abstract][Full Text] [Related]
12. Evidence implicating a role for orexin-1 receptor modulation of paradoxical sleep in the rat.
Smith MI; Piper DC; Duxon MS; Upton N
Neurosci Lett; 2003 May; 341(3):256-8. PubMed ID: 12697296
[TBL] [Abstract][Full Text] [Related]
13. Orexins: effects on behavior and localisation of orexin receptor 2 messenger ribonucleic acid in the rat brainstem.
Sunter D; Morgan I; Edwards CM; Dakin CL; Murphy KG; Gardiner J; Taheri S; Rayes E; Bloom SR
Brain Res; 2001 Jul; 907(1-2):27-34. PubMed ID: 11430882
[TBL] [Abstract][Full Text] [Related]
14. Hypocretin-1 dose-dependently modulates maternal behaviour in mice.
D'Anna KL; Gammie SC
J Neuroendocrinol; 2006 Aug; 18(8):553-66. PubMed ID: 16867176
[TBL] [Abstract][Full Text] [Related]
15. Orexins and the treatment of obesity.
Smart D; Haynes AC; Williams G; Arch JR
Eur J Pharmacol; 2002 Apr; 440(2-3):199-212. PubMed ID: 12007536
[TBL] [Abstract][Full Text] [Related]
16. Role of leptin in the control of feeding of goldfish Carassius auratus: interactions with cholecystokinin, neuropeptide Y and orexin A, and modulation by fasting.
Volkoff H; Eykelbosh AJ; Peter RE
Brain Res; 2003 May; 972(1-2):90-109. PubMed ID: 12711082
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory effect of intracerebroventricular administration of orexin A on food intake in the zebrafish, Danio rerio.
Yokobori E; Kojima K; Azuma M; Kang KS; Maejima S; Uchiyama M; Matsuda K
Peptides; 2011 Jul; 32(7):1357-62. PubMed ID: 21616109
[TBL] [Abstract][Full Text] [Related]
18. Orexin-1 receptor mediates the increased food and water intake induced by intracerebroventricular injection of the stable somatostatin pan-agonist, ODT8-SST in rats.
Karasawa H; Yakabi S; Wang L; Taché Y
Neurosci Lett; 2014 Jul; 576():88-92. PubMed ID: 24915296
[TBL] [Abstract][Full Text] [Related]
19. Role of the ventromedial hypothalamic orexin-1 receptors in regulation of gastric Acid secretion in conscious rats.
Eliassi A; Nazari M; Naghdi N
J Neuroendocrinol; 2009 Mar; 21(3):177-82. PubMed ID: 19207823
[TBL] [Abstract][Full Text] [Related]
20. Orexin receptor type-1 antagonist SB-334867 decreases morphine-induced antinociceptive effect in formalin test.
Azhdari-Zarmehri H; Esmaeili MH; Sofiabadi M; Haghdoost-Yazdi H
Pharmacol Biochem Behav; 2013 Nov; 112():64-70. PubMed ID: 24125787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
